Open AccessOutcomes of anatomical vs. functional testing for coronary artery disease
Author(s) -
Júlia Karády,
Jana Taron,
Andreas A. Kammerlander,
Udo Hoffmann
Publication year - 2020
Publication title -
herz
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.374
H-Index - 51
eISSN - 1615-6692
pISSN - 0340-9937
DOI - 10.1007/s00059-020-04950-y
Subject(s) - medicine , coronary artery disease , fractional flow reserve , chest pain , revascularization , radiology , cardiology , angiography , functional testing , cad , coronary angiography , medline , myocardial infarction , engineering drawing , political science , law , engineering
Management of patients presenting with suspected stable coronary artery disease (CAD) are challenging because estimation of pretest probability for obstructive CAD remains difficult. In addition, identification of those who benefit from coronary revascularization remains ineffective regardless of the wide array of noninvasive testing alternatives available. Functional testing, which has long been considered to be the test of choice to risk stratify these patients, shows modest agreement with CAD severity detected by invasive coronary angiography and has been reported to be ineffective in settings of low prevalence of obstructive CAD. A growing body of evidence demonstrates the excellent diagnostic accuracy as well as prognostic value of coronary computed tomography (CT) angiography especially in conjunction with noninvasive fractional flow reserve (FFR) testing, challenging the primary role of functional testing especially in patients without prior or known CAD. Landmark trials, including the Prospective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) and Scottish Computed Tomography of the Heart (SCOT-HEART), have contributed to a better understanding of how coronary CT angiography may play a role in more efficient management and even improved health outcomes. The emerging role of coronary CT has been acknowledged by the 2019 Guidelines of the European Society of Cardiology recommending the use of CT as a first-line tool for the evaluation of patients with stable chest pain with a class I, level of evidence B recommendation. The purpose of this article is to provide an overview on existing evidence, clinical implication, limitations of available data, and remaining questions to be answered by future research.